ITASCA, IL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)ILLINOIS TRANSPLANT FUND, founded in 2015, is a small nonprofit in the Philanthropy & Grantmaking sector that reported $827K in total revenue in fiscal year 2024. Revenue surged 152% from the prior year, signaling strong growth momentum.
THE MISSION OF THE ILLINOIS TRANSPLANT FUND IS TO GIVE PEOPLE ACCESS TO LIFESAVING ORGAN TRANSPLANTS AND FOLLOW-UP CARE TO HELP THEM LIVE LONG, HEALTHY AND PRODUCTIVE LIVES. CONTINUED ON SCHEDULE OWE CARRY OUT OUR MISSION BY PROVIDING FINANCIAL ASSISTANCE IN THE FORM OF INSURANCE PREMIUM SUPPORT TO QUALIFIED PARTICIPANTS IN NEED. WITHOUT THIS ASSISTANCE, MANY PEOPLE WILL NOT QUALIFY TO RECEIVE AN ORGAN TRANSPLANT. AS OF 12/31/24, ILLINOIS TRANSPLANT FUND HAS SUPPORTED PATIENTS THAT HAVE RECEIVED OVER 600 LIFESAVING ORGAN TRANSPLANTS.
PROVIDE INSURANCE PREMIUM SUPPORT TO OUR QUALIFIED PARTICIPANTS. COVERAGE IS FOR ORGAN TRANSPLANTS AND POST TRANSPLANT CARE TO SUPPORT OUR MISSION OF "GIVING PEOPLE ACCESS TO LIFESAVING ORGAN...
PROVIDE INSURANCE PREMIUM SUPPORT TO OUR QUALIFIED PARTICIPANTS. COVERAGE IS FOR ORGAN TRANSPLANTS AND POST TRANSPLANT CARE TO SUPPORT OUR MISSION OF "GIVING PEOPLE ACCESS TO LIFESAVING ORGAN TRANSPLANTS AND FOLLOW-UP CARE TO HELP THEM LIVE LONG, HEALTHY AND PRODUCTIVE LIVES." WE HAVE SUPPORTED 141 PARTICIPANTS DURING 2024, WITH PLANS TO SUPPORT 157 PARTICIPANTS IN 2025.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $826,537 | $328,073 | +1.5% |
| Expenses | $882,279 | $669,992 | +0.3% |
| Net Income | $-55,742 | $-341,919 | -0.8% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| HARRY E WILKINS III MD | PRESIDENT/CEO | 2.00 |
Officer
Director
|
$0 | $49,452 | $634,894 |
| ROSS RASPOPOVICH | DIRECTOR | 1.00 |
Director
|
$0 | $74,336 | $442,850 |
| AUDRENA SPENCE | EXECUTIVE DIRECTOR (UNTIL 02/25/24) | 1.00 |
Director
|
$0 | $65,975 | $250,798 |
| J KEVIN CMUNT | TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $32,496 |
| BEVERLEY KETEL MD | CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| JOSEPH O'CONNOR | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| JENNIFER AGUILAR | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| OGBONNAYA ANEZIOKORO MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| HUGO BALTA | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| LETICIA GARCIA | DIRECTOR (UNTIL 12/30/24) | 1.00 |
Director
|
$0 | $0 | $0 |
| GERARDO HUERTA | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| BLANCA JARA | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| CESAR ROLON JR | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ANDRES SERRANO | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| CHRISTINA TREVIZO | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $826,537 | $882,279 | $448,722 | $-55,742 |
| 2023 | $328,073 | $669,992 | $502,788 | $-341,919 |
| 2022 | $900,983 | $792,273 | $837,928 | $108,710 |
| 2021 | $310,174 | $940,914 | $730,170 | $-630,740 |
| 2020 | $1,505,405 | $824,116 | $1,359,187 | $681,289 |
| 2019 | $909,641 | $750,489 | $692,563 | $159,152 |
| 2018 | $146,805 | $528,239 | $527,574 | $-381,434 |
Compare ILLINOIS TRANSPLANT FUND with other nonprofits in Illinois and across the country.